Coherus BioSciences, Inc. 4
4 · Coherus BioSciences, Inc. · Filed Nov 16, 2015
Insider Transaction Report
Form 4
Richards Christos
Director
Transactions
- Sale
Common Stock, $0.0001 par value
2015-11-13$27.93/sh−4,012$112,051→ 63,836 total - Sale
Common Stock, $0.0001 par value
2015-11-12$27.23/sh−3,000$81,693→ 75,836 total - Sale
Common Stock, $0.0001 par value
2015-11-13$27.38/sh−7,988$218,681→ 67,848 total
Footnotes (3)
- [F1]The transaction was executed in multiple trades in prices ranging from $26.88 to $27.58, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- [F2]The transaction was executed in multiple trades in prices ranging from $26.69 to $27.66, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- [F3]The transaction was executed in multiple trades in prices ranging from $27.70 to $28.29, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.